Table Info

Table 1.

Fructose (and glucose) content of different foods

Food	Free fructose (g)/100 g	Total fructose (g)/100 g^a	Free glucose (g)/100 g	Total glucose (g)/100 g^a
Apple juice	6.8	8.3	2.4	3.9
Orange juice	2.5	4.2	2.6	4.3
Banana	3.4	8.6	3.5	8.7
Kaki	8.0	8.5	7.0	7.5
Pear	6.7	7.6	1.7	2.6
Apple	5.7	7.0	2.0	3.3
Watermelon	3.9	5.1	2.0	3.2
Orange	2.6	4.3	2.3	4.0
Grapefruit	2.1	3.6	2.4	3.9
Strawberry	2.2	2.7	2.2	2.7
Beetroot	0.3	4.3	0.3	4.3
Sweet pepper (red)	3.7	3.8	2.3	2.4
Carrot	0.8	3.2	0.8	3.2
Sweet pepper (green)	1.2	1.3	1.5	1.6
Cucumber	0.9	1.0	0.9	1.0
Potato	0.2	0.4	0.2	0.4
Spinach	0.1	0.2	0.1	0.2
Yoghurt (fruit)	0.5	5.9	0.2	5.6
Milk	0	0	0	0
Yoghurt	0	0	0	0
Honey	38.8	40	33.9	35.1

Data from software EBISpro (version 8.0, 2007, Germany) based on Bundeslebensmittelschlüssel, Germany.

Total fructose/glucose derived from sucrose and free fructose/glucose

Declarations

Author contributions

A Baumann: visualization, writing original draft preparation and review, and editing; A Brandt: visualization, writing original draft preparation and review, and editing; IB: conceptualization, supervision, writing original draft and review, and editing. All authors reviewed and approved to the final version of the manuscript.

Conflicts of interest

The authors declare that they have no conflicts of interest related to the present work.

Ethical approval

Not applicable.

Consent to participate

Not applicable.

Consent to publication

Not applicable.

Availability of data and materials

Not applicable.

Funding

Not applicable.

Copyright

References

Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep. 2018;20:12. [DOI] [PubMed] [PMC]

Mirmiran P, Amirhamidi Z, Ejtahed HS, Bahadoran Z, Azizi F. Relationship between diet and non-alcoholic fatty liver disease: a review article. Iran J Public Health. 2017;46:1007–17. [PubMed] [PMC]

Malik VS, Hu FB. The role of sugar-sweetened beverages in the global epidemics of obesity and chronic diseases. Nat Rev Endocrinol. 2022;18:205–18. [DOI] [PubMed] [PMC]

Stanhope KL, Schwarz JM, Keim NL, Griffen SC, Bremer AA, Graham JL, et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest. 2009;119:1322–34. [DOI] [PubMed] [PMC]

Perez-Pozo SE, Schold J, Nakagawa T, Sanchez-Lozada LG, Johnson RJ, Lillo JL. Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response. Int J Obes (Lond). 2010;34:454–61. [DOI] [PubMed]

Maersk M, Belza A, Stodkilde-Jorgensen H, Ringgaard S, Chabanova E, Thomsen H, et al. Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study. Am J Clin Nutr. 2012;95:283–9. [DOI] [PubMed]

Nier A, Brandt A, Rajcic D, Bruns T, Bergheim I. Short-term isocaloric intake of a fructose- but not glucose-rich diet affects bacterial endotoxin concentrations and markers of metabolic health in normal weight healthy subjects. Mol Nutr Food Res. 2019;63:1800868. [DOI] [PubMed] [PMC]

Wong SK, Chin KY, Suhaimi FH, Fairus A, Ima-Nirwana S. Animal models of metabolic syndrome: a review. Nutr Metab (Lond). 2016;13:65. [DOI] [PubMed] [PMC]

Kavanagh K, Wylie AT, Tucker KL, Hamp TJ, Gharaibeh RZ, Fodor AA, et al. Dietary fructose induces endotoxemia and hepatic injury in calorically controlled primates. Am J Clin Nutr. 2013;98:349–57. [DOI] [PubMed] [PMC]

10.

Page KA, Chan O, Arora J, Belfort-Deaguiar R, Dzuira J, Roehmholdt B, et al. Effects of fructose vs glucose on regional cerebral blood flow in brain regions involved with appetite and reward pathways. JAMA. 2013;309:63–70. [DOI] [PubMed] [PMC]

11.

Luo S, Monterosso JR, Sarpelleh K, Page KA. Differential effects of fructose versus glucose on brain and appetitive responses to food cues and decisions for food rewards. Proc Natl Acad Sci U S A. 2015;112:6509–14. [DOI] [PubMed] [PMC]

12.

Rayner CK, Park HS, Wishart JM, Kong M, Doran SM, Horowitz M. Effects of intraduodenal glucose and fructose on antropyloric motility and appetite in healthy humans. Am J Physiol Regul Integr Comp Physiol. 2000;278:R360–6. [DOI] [PubMed]

13.

Steinert RE, Frey F, Topfer A, Drewe J, Beglinger C. Effects of carbohydrate sugars and artificial sweeteners on appetite and the secretion of gastrointestinal satiety peptides. Br J Nutr. 2011;105:1320–8. [DOI] [PubMed]

14.

Yau AMW, McLaughlin J, Maughan RJ, Gilmore W, Evans GH. The effect of short-term dietary fructose supplementation on gastric emptying rate and gastrointestinal hormone responses in healthy men. Nutrients. 2017;9:258. [DOI] [PubMed] [PMC]

15.

Meyer-Gerspach AC, Biesiekierski JR, Deloose E, Clevers E, Rotondo A, Rehfeld JF, et al. Effects of caloric and noncaloric sweeteners on antroduodenal motility, gastrointestinal hormone secretion and appetite-related sensations in healthy subjects. Am J Clin Nutr. 2018;107:707–16. [DOI] [PubMed]

16.

Della Corte KW, Perrar I, Penczynski KJ, Schwingshackl L, Herder C, Buyken AE. Effect of dietary sugar intake on biomarkers of subclinical inflammation: a systematic review and meta-analysis of intervention studies. Nutrients. 2018;10:606. [DOI] [PubMed] [PMC]

17.

Evans GH, McLaughlin J, Yau AMW. The effect of glucose or fructose added to a semi-solid meal on gastric emptying rate, appetite, and blood biochemistry. Front Nutr. 2018;5:94. [DOI] [PubMed] [PMC]

18.

Silbernagel G, Machann J, Häring HU, Fritsche A, Peter A. Plasminogen activator inhibitor-1, monocyte chemoattractant protein-1, e-selectin and C-reactive protein levels in response to 4-week very-high-fructose or -glucose diets. Eur J Clin Nutr. 2014;68:97–100. [DOI] [PubMed]

19.

Smajis S, Gajdosik M, Pfleger L, Traussnigg S, Kienbacher C, Halilbasic E, et al. Metabolic effects of a prolonged, very-high-dose dietary fructose challenge in healthy subjects. Am J Clin Nutr. 2020;111:369–77. [DOI] [PubMed]

20.

Sluik D, Engelen AI, Feskens EJ. Fructose consumption in the Netherlands: the Dutch national food consumption survey 2007–2010. Eur J Clin Nutr. 2015;69:475–81. [DOI] [PubMed]

21.

Hanover LM, White JS. Manufacturing, composition, and applications of fructose. Am J Clin Nutr. 1993;58:724S–32S. [DOI] [PubMed]

22.

US Department of Agriculture [Internet]. Sugar and Sweeteners Yearbook Tables; c2019 [updated 2019 Jun 24; cited 2022 Apr 19]. Available from: https://www.ers.usda.gov/data-products/sugar-and-sweeteners-yearbook-tables.aspx

23.

Marriott BP, Hunt KJ, Malek AM, Newman JC. Trends in intake of energy and total sugar from sugar-sweetened beverages in the United States among children and adults, NHANES 2003–2016. Nutrients. 2019;11:2004. [DOI] [PubMed] [PMC]

24.

Drewnowski A, Rehm CD. Consumption of added sugars among US children and adults by food purchase location and food source. Am J Clin Nutr. 2014;100:901–7. [DOI] [PubMed] [PMC]

25.

World Health Organization [Internet]. Guideline: Sugars Intake for Adults and Children; c2015 [updated 2015 Mar 4; cited 2022 Apr 19]. Available from: https://www.who.int/publications/i/item/9789241549028

26.

Azais-Braesco V, Sluik D, Maillot M, Kok F, Moreno LA. A review of total & added sugar intakes and dietary sources in Europe. Nutr J. 2017;16:6. [DOI] [PubMed] [PMC]

27.

Thuy S, Ladurner R, Volynets V, Wagner S, Strahl S, Konigsrainer A, et al. Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake. J Nutr. 2008;138:1452–5. [DOI] [PubMed]

28.

Volynets V, Kuper MA, Strahl S, Maier IB, Spruss A, Wagnerberger S, et al. Nutrition, intestinal permeability, and blood ethanol levels are altered in patients with nonalcoholic fatty liver disease (NAFLD). Dig Dis Sci. 2012;57:1932–41. [DOI] [PubMed]

29.

Weber KS, Simon MC, Strassburger K, Markgraf DF, Buyken AE, Szendroedi J, et al. Habitual fructose intake relates to insulin sensitivity and fatty liver index in recent-onset type 2 diabetes patients and individuals without diabetes. Nutrients. 2018;10:774. [DOI] [PubMed] [PMC]

30.

Crane RK. Hypothesis for mechanism of intestinal active transport of sugars. Fed Proc. 1962;21:891–5. [PubMed]

31.

Drozdowski LA, Thomson AB. Intestinal sugar transport. World J Gastroenterol. 2006;12:1657–70. [DOI] [PubMed] [PMC]

32.

Wright EMI. Glucose galactose malabsorption. Am J Physiol Gastrointest Liver Physiol. 1998;275:G879–82. [DOI] [PubMed]

33.

Kellett GL, Brot-Laroche E. Apical GLUT2: a major pathway of intestinal sugar absorption. Diabetes. 2005;54:3056–62. [DOI] [PubMed]

34.

Merino B, Fernández-Díaz CM, Cózar-Castellano I, Perdomo G. Intestinal fructose and glucose metabolism in health and disease. Nutrients. 2020;12:94. [DOI] [PubMed] [PMC]

35.

Gouyon F, Caillaud L, Carriere V, Klein C, Dalet V, Citadelle D, et al. Simple-sugar meals target GLUT2 at enterocyte apical membranes to improve sugar absorption: a study in GLUT2-null mice. J Physiol. 2003;552:823–32. [DOI] [PubMed] [PMC]

36.

Helliwell PA, Richardson M, Affleck J, Kellett GL. Regulation of GLUT5, GLUT2 and intestinal brush-border fructose absorption by the extracellular signal-regulated kinase, p38 mitogen-activated kinase and phosphatidylinositol 3-kinase intracellular signalling pathways: implications for adaptation to diabetes. Biochem J. 2000;350 Pt 1:163–9. [DOI] [PubMed] [PMC]

37.

Sun SZ, Empie MW. Fructose metabolism in humans—what isotopic tracer studies tell us. Nutr Metab (Lond). 2012;9:89. [DOI] [PubMed] [PMC]

38.

Riby JE, Fujisawa T, Kretchmer N. Fructose absorption. Am J Clin Nutr. 1993;58:748s–53s. [DOI] [PubMed]

39.

Barrett JS, Gearry RB, Muir JG, Irving PM, Rose R, Rosella O, et al. Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon. Aliment Pharmacol Ther. 2010;31:874–82. [DOI] [PubMed]

40.

Patel C, Sugimoto K, Douard V, Shah A, Inui H, Yamanouchi T, et al. Effect of dietary fructose on portal and systemic serum fructose levels in rats and in KHK^-/- and GLUT5^-/- mice. Am J Physiol Gastrointest Liver Physiol. 2015;309:G779–90. [DOI] [PubMed] [PMC]

41.

Francey C, Cros J, Rosset R, Creze C, Rey V, Stefanoni N, et al. The extra-splanchnic fructose escape after ingestion of a fructose-glucose drink: an exploratory study in healthy humans using a dual fructose isotope method. Clin Nutr ESPEN. 2019;29:125–32. [DOI] [PubMed]

42.

Bode C, Bode JC, Ohta W, Martini GA. Adaptative changes of activity of enzymes involved in fructose metabolism in the liver and jejunal mucosa of rats following fructose feeding. Res Exp Med (Berl). 1980;178:55–63. [DOI] [PubMed]

43.

Teff KL, Grudziak J, Townsend RR, Dunn TN, Grant RW, Adams SH, et al. Endocrine and metabolic effects of consuming fructose- and glucose-sweetened beverages with meals in obese men and women: influence of insulin resistance on plasma triglyceride responses. J Clin Endocrinol Metab. 2009;94:1562–9. [DOI] [PubMed] [PMC]

44.

Jang C, Hui S, Lu W, Cowan AJ, Morscher RJ, Lee G, et al. The small intestine converts dietary fructose into glucose and organic acids. Cell Metab. 2018;27:351–61.E3. [DOI] [PubMed] [PMC]

45.

Haidari M, Leung N, Mahbub F, Uffelman KD, Kohen-Avramoglu R, Lewis GF, et al. Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance. Evidence that chronic fructose feeding in the hamster is accompanied by enhanced intestinal de novo lipogenesis and ApoB48-containing lipoprotein overproduction. J Biol Chem. 2002;277:31646–55. [DOI] [PubMed]

46.

Steenson S, Umpleby AM, Lovegrove JA, Jackson KG, Fielding BA. Role of the enterocyte in fructose-induced hypertriglyceridaemia. Nutrients. 2017;9:349. [DOI] [PubMed] [PMC]

47.

Koepsell H. Glucose transporters in the small intestine in health and disease. Pflugers Arch. 2020;472:1207–48. [DOI] [PubMed] [PMC]

48.

Mayes PA. Intermediary metabolism of fructose. Am J Clin Nutr. 1993;58:754s–65s. [DOI] [PubMed]

49.

Tappy L. Fructose metabolism and noncommunicable diseases: recent findings and new research perspectives. Curr Opin Clin Nutr Metab Care. 2018;21:214–22. [DOI] [PubMed]

50.

Herman MA, Birnbaum MJ. Molecular aspects of fructose metabolism and metabolic disease. Cell Metab. 2021;33:2329–54. [DOI] [PubMed]

51.

Jensen T, Abdelmalek MF, Sullivan S, Nadeau KJ, Green M, Roncal C, et al. Fructose and sugar: a major mediator of non-alcoholic fatty liver disease. J Hepatol. 2018;68:1063–75. [DOI] [PubMed] [PMC]

52.

Van den Berghe G. Fructose: metabolism and short-term effects on carbohydrate and purine metabolic pathways. Prog Biochem Pharmacol. 1986;21:1–32. [PubMed]

53.

Tappy L, Rosset R. Health outcomes of a high fructose intake: the importance of physical activity. J Physiol. 2019;597:3561–71. [DOI] [PubMed] [PMC]

54.

Tran LT, Yuen VG, McNeill JH. The fructose-fed rat: a review on the mechanisms of fructose-induced insulin resistance and hypertension. Mol Cell Biochem. 2009;332:145–59. [DOI] [PubMed]

55.

Silbernagel G, Machann J, Unmuth S, Schick F, Stefan N, Haring HU, et al. Effects of 4-week very-high-fructose/glucose diets on insulin sensitivity, visceral fat and intrahepatic lipids: an exploratory trial. Br J Nutr. 2011;106:79–86. [DOI] [PubMed]

56.

Wang DD, Sievenpiper JL, de Souza RJ, Cozma AI, Chiavaroli L, Ha V, et al. Effect of fructose on postprandial triglycerides: a systematic reviewand meta-analysis of controlled feeding trials. Artherosclerosis. 2014;232:125–33. [DOI] [PubMed]

57.

Wang H, Astarita G, Taussig MD, Bharadwaj KG, DiPatrizio NV, Nave KA, et al. Deficiency of lipoprotein lipase in neurons modifies the regulation of energy balance and leads to obesity. Cell Metab. 2011;13:105–13. [DOI] [PubMed] [PMC]

58.

Chiavaroli L, de Souza RJ, Ha V, Cozma AI, Mirrahimi A, Wang DD, et al. Effect of fructose on established lipid targets: a systematic review and meta-analysis of controlled feeding trials. J Am Heart Assoc. 2015;4:e001700. [DOI] [PubMed] [PMC]

59.

Hieronimus B, Griffen SC, Keim NL, Bremer AA, Berglund L, Nakajima K, et al. Effects of fructose or glucose on circulating ApoCIII and triglyceride and cholesterol content of lipoprotein subfractions in humans. J Clin Med. 2019;8:913. [DOI] [PubMed] [PMC]

60.

Te Morenga LA, Howatson AJ, Jones RM, Mann J. Dietary sugars and cardiometabolic risk: systematic review and meta-analyses of randomized controlled trials of the effects on blood pressure and lipids. Am J Clin Nutr. 2014;100:65–79. [DOI] [PubMed]

61.

Tappy L, Randin JP, Felber JP, Chiolero R, Simonson DC, Jequier E, et al. Comparison of thermogenic effect of fructose and glucose in normal humans. Am J Physiol. 1986;250:E718–24. [DOI] [PubMed]

62.

Abdel-Sayed A, Binnert C, Le KA, Bortolotti M, Schneiter P, Tappy L. A high-fructose diet impairs basal and stress-mediated lipid metabolism in healthy male subjects. Br J Nutr. 2008;100:393–9. [DOI] [PubMed]

63.

Morigny P, Houssier M, Mouisel E, Langin D. Adipocyte lipolysis and insulin resistance. Biochimie. 2016;125:259–66. [DOI] [PubMed]

64.

Miller M, Stone NJ, Ballantyne C, Bittner V, Criqui MH, Ginsberg HN, et al. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2011;123:2292–333. [DOI] [PubMed]

65.

Tappy L, Morio B, Azzout-Marniche D, Champ M, Gerber M, Houdart S, et al. French recommendations for sugar intake in adults: a novel approach chosen by ANSES. Nutrients. 2018;10:989. [DOI] [PubMed] [PMC]

66.

Government UK [Internet]. The Scientific Advisory Committee on Nutrition Recommendations on Carbohydrates, Including Sugars and Fibre; c2015 [cited 2022 Apr 19]. Available from: https://www.gov.uk/government/publications/sacn-carbohydrates-and-health-report

67.

Johnson RK, Appel LJ, Brands M, Howard BV, Lefevre M, Lustig RH, et al. Dietary sugars intake and cardiovascular health: a scientific statement from the American Heart Association. Circulation. 2009;120:1011–20. [DOI] [PubMed]

68.

Adams SH, Stanhope KL, Grant RW, Cummings BP, Havel PJ. Metabolic and endocrine profiles in response to systemic infusion of fructose and glucose in rhesus macaques. Endocrinology. 2008;149:3002–8. [DOI] [PubMed] [PMC]

69.

Baly DL, Curry DL, Keen CL, Hurley LS. Effect of manganese deficiency on insulin secretion and carbohydrate homeostasis in rats. J Nutr. 1984;114:1438–46. [DOI] [PubMed]

70.

Thorburn AW, Storlien LH, Jenkins AB, Khouri S, Kraegen E. Fructose-induced in vivo insulin resistance and elevated plasma triglyceride levels in rats. Am J Clin Nutr. 1989;49:1155–63. [DOI] [PubMed]

71.

Spruss A, Kanuri G, Wagnerberger S, Haub S, Bischoff SC, Bergheim I. Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice. Hepatology. 2009;50:1094–104. [DOI] [PubMed]

72.

ter Horst KW, Schene MR, Holman R, Romijn JA, Serlie MJ. Effect of fructose consumption on insulin sensitivity in nondiabetic subjects: a systematic review and meta-analysis of diet-intervention trials. Am J Clin Nutr. 2016;104:1562–76. [DOI] [PubMed]

73.

Micha R, Shulkin ML, Penalvo JL, Khatibzadeh S, Singh GM, Rao M, et al. Etiologic effects and optimal intakes of foods and nutrients for risk of cardiovascular diseases and diabetes: systematic reviews and meta-analyses from the Nutrition and Chronic Diseases Expert Group (NutriCoDE). PLoS One. 2017;12:e0175149. [DOI] [PubMed] [PMC]

74.

Bergheim I, Weber S, Vos M, Kramer S, Volynets V, Kaserouni S, et al. Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin. J Hepatol. 2008;48:983–92. [DOI] [PubMed]

75.

Sellmann C, Priebs J, Landmann M, Degen C, Engstler AJ, Jin CJ, et al. Diets rich in fructose, fat or fructose and fat alter intestinal barrier function and lead to the development of nonalcoholic fatty liver disease over time. J Nutr Biochem. 2015;26:1183–92. [DOI] [PubMed]

76.

Cozma AI, Sievenpiper JL, de Souza RJ, Chiavaroli L, Ha V, Wang DD, et al. Effect of fructose on glycemic control in diabetes: a systematic review and meta-analysis of controlled feeding trials. Diabetes Care. 2012;35:1611–20. [DOI] [PubMed] [PMC]

77.

Imamura F, O’Connor L, Ye Z, Mursu J, Hayashino Y, Bhupathiraju SN, et al. Consumption of sugar sweetened beverages, artificially sweetened beverages, and fruit juice and incidence of type 2 diabetes: systematic review, meta-analysis, and estimation of population attributable fraction. BMJ. 2015;351:h3576. [DOI] [PubMed] [PMC]

78.

Malik VS, Popkin BM, Bray GA, Despres JP, Willett WC, Hu FB. Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care. 2010;33:2477–83. [DOI] [PubMed] [PMC]

79.

Semnani-Azad Z, Khan TA, Blanco Mejia S, de Souza RJ, Leiter LA, Kendall CWC, et al. Association of major food sources of fructose-containing sugars with incident metabolic syndrome: a systematic review and meta-analysis. JAMA Netw Open. 2020;3:e209993. [DOI] [PubMed] [PMC]

80.

Softic S, Stanhope KL, Boucher J, Divanovic S, Lanaspa MA, Johnson RJ, et al. Fructose and hepatic insulin resistance. Crit Rev Clin Lab Sci. 2020;57:308–22. [DOI] [PubMed] [PMC]

81.

Yu S, Li C, Ji G, Zhang L. The contribution of dietary fructose to non-alcoholic fatty liver disease. Front Pharmacol. 2021:12:783393. [DOI] [PubMed] [PMC]

82.

Nagai Y, Yonemitsu S, Erion DM, Iwasaki T, Stark R, Weismann D, et al. The role of peroxisome proliferator-activated receptor γ coactivator-1 β in the pathogenesis of fructose-induced insulin resistance. Cell Metab. 2009;9:252–64. [DOI] [PubMed] [PMC]

83.

Samuel VT, Liu ZX, Qu X, Elder BD, Bilz S, Befroy D, et al. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem. 2004;279:32345–53. [DOI] [PubMed]

84.

Kumashiro N, Erion DM, Zhang D, Kahn M, Beddow SA, Chu X, et al. Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease. Proc Natl Acad Sci U S A. 2011;108:16381–5. [DOI] [PubMed] [PMC]

85.

Skenderian S, Park G, Jang C. Organismal fructose metabolism in health and non-alcoholic fatty liver disease. Biology. 2020;9:405. [DOI] [PubMed] [PMC]

86.

Lambertz J, Weiskirchen S, Landert S, Weiskirchen R. Fructose: a dietary sugar in crosstalk with microbiota contributing to the development and progression of non-alcoholic liver disease. Front Immunol. 2017;8:1159. [DOI] [PubMed] [PMC]

87.

Patil R, Arvindekar A. Glycation of gut proteins initiates microbial dysbiosis and can promote establishment of diabetes in experimental animals. Microb Pathog. 2021;152:104589. [DOI] [PubMed]

88.

Spruss A, Kanuri G, Uebel K, Bischoff SC, Bergheim I. Role of the inducible nitric oxide synthase in the onset of fructose-induced steatosis in mice. Antioxid Redox Signal. 2011;14:2121–35. [DOI] [PubMed]

89.

Kanuri G, Spruss A, Wagnerberger S, Bischoff SC, Bergheim I. Role of tumor necrosis factor α (TNFα) in the onset of fructose-induced nonalcoholic fatty liver disease in mice. J Nutr Biochem. 2011;22:527–34. [DOI] [PubMed]

90.

Brandt A, Jin CJ, Nolte K, Sellmann C, Engstler AJ, Bergheim I. Short-term intake of a fructose-, fat- and cholesterol-rich diet causes hepatic steatosis in mice: effect of antibiotic treatment. Nutrients. 2017;9:1013. [DOI] [PubMed] [PMC]

91.

Jin CJ, Engstler AJ, Ziegenhardt D, Bischoff SC, Trautwein C, Bergheim I. Loss of lipopolysaccharide- binding protein attenuates the development of diet-induced non-alcoholic fatty liver disease in mice. J Gastroenterol Hepatol. 2017;32:708–15. [DOI] [PubMed]

92.

Kim MS, Krawczyk SA, Doridot L, Fowler AJ, Wang JX, Trauger SA, et al. ChREBP regulates fructose-induced glucose production independently of insulin signaling. J Clin Invest. 2016;126:4372–86. [DOI] [PubMed] [PMC]

93.

Noronha JC, Braunstein CR, Glenn AJ, Khan TA, Viguiliouk E, Noseworthy R, et al. The effect of small doses of fructose and allulose on postprandial glucose metabolism in type 2 diabetes: a double-blind, randomized, controlled, acute feeding, equivalence trial. Diabetes Obes Metab. 2018;20:2361–70. [DOI] [PubMed] [PMC]

94.

Moore MC, Cherrington AD, Mann SL, Davis SN. Acute fructose administration decreases the glycemic response to an oral glucose tolerance test in normal adults. J Clin Endocrinol Metab. 2000;85:4515–9. [DOI] [PubMed]

95.

Moore MC, Davis SN, Mann SL, Cherrington AD. Acute fructose administration improves oral glucose tolerance in adults with type 2 diabetes. Diabetes Care. 2001;24:1882–7. [DOI] [PubMed]

96.

Sievenpiper JL, Chiavaroli L, de Souza RJ, Mirrahimi A, Cozma AI, Ha V, et al. ‘Catalytic’ doses of fructose may benefit glycaemic control without harming cardiometabolic risk factors: a small meta-analysis of randomised controlled feeding trials. Br J Nutr. 2012;108:418–23. [DOI] [PubMed] [PMC]

97.

Chen HH, Chu CH, Wen SW, Lai CC, Cheng PW, Tseng CJ. Excessive fructose intake impairs baroreflex sensitivity and led to elevated blood pressure in rats. Nutrients. 2019;11:2581. [DOI] [PubMed] [PMC]

98.

Cheng PW, Lin YT, Ho WY, Lu PJ, Chen HH, Lai CC, et al. Fructose induced neurogenic hypertension mediated by overactivation of p38 MAPK to impair insulin signaling transduction caused central insulin resistance. Free Radic Biol Med. 2017;112:298–307. [DOI] [PubMed]

99.

Dai S, McNeill JH. Fructose-induced hypertension in rats is concentration- and duration-dependent. J Pharmacol Toxicol Methods. 1995;33:101–7. [DOI] [PubMed]

100.

Busnatu SS, Salmen T, Pana MA, Rizzo M, Stallone T, Papanas N, et al. The role of fructose as a cardiovascular risk factor: an update. Metabolites. 2022;12:67. [DOI] [PubMed] [PMC]

101.

Bahadoran Z, Mirmiran P, Tohidi M, Azizi F. Longitudinal associations of high-fructose diet with cardiovascular events and potential risk factors: Tehran lipid and glucose study. Nutrients. 2017;9:872. [DOI] [PubMed] [PMC]

102.

Scott S, Young J, Lodge JK. A pilot feasibility study investigating the impact of increasing sucrose intakes on body composition and blood pressure. J Nutr Sci. 2021;10:E60. [DOI] [PubMed] [PMC]

103.

Ha V, Sievenpiper JL, de Souza RJ, Chiavaroli L, Wang DD, Cozma AI, et al. Effect of fructose on blood pressure: a systematic review and meta-analysis of controlled feeding trials. Hypertension. 2012;59:787–95. [DOI] [PubMed]

104.

Liu Q, Ayoub-Charette S, Khan TA, Au-Yeung F, Blanco Mejia S, de Souza RJ, et al. Important food sources of fructose-containing sugars and incident hypertension: a systematic review and dose-response meta-analysis of prospective cohort studies. J Am Heart Assoc. 2019;8:e010977. [DOI] [PubMed] [PMC]

105.

Gugliucci A, Lustig RH, Caccavello R, Erkin-Cakmak A, Noworolski SM, Tai VW, et al. Short-term isocaloric fructose restriction lowers apoC-III levels and yields less atherogenic lipoprotein profiles in children with obesity and metabolic syndrome. Atherosclerosis. 2016;253:171–7. [DOI] [PubMed]

106.

Brymora A, Flisinski M, Johnson RJ, Goszka G, Stefanska A, Manitius J. Low-fructose diet lowers blood pressure and inflammation in patients with chronic kidney disease. Nephrol Dial Transplant. 2012;27:608–12. [DOI] [PubMed] [PMC]

107.

Madero M, Rodriguez Castellanos FE, Jalal D, Villalobos-Martin M, Salazar J, Vazquez-Rangel A, et al. A pilot study on the impact of a low fructose diet and allopurinol on clinic blood pressure among overweight and prehypertensive subjects: a randomized placebo controlled trial. J Am Soc Hypertens. 2015;9:837–44. [DOI] [PubMed]

108.

Brandhorst S, Longo VD. Dietary restrictions and nutrition in the prevention and treatment of cardiovascular disease. Circulation Research. 2019;124:952–65. [DOI] [PubMed]

109.

Klein AV, Kiat H. The mechanisms underlying fructose-induced hypertension: a review. J Hypertens. 2015;33:912–20. [DOI] [PubMed] [PMC]

110.

Drożdż K, Nabrdalik K, Hajzler W, Kwiendacz H, Gumprecht J, Lip GYH. Metabolic-associated fatty liver disease (MAFLD), diabetes, and cardiovascular disease: associations with fructose metabolism and gut microbiota. Nutrients. 2022;14:103. [DOI] [PubMed] [PMC]

111.

Ha SK. Dietary salt intake and hypertension. Electrolyte Blood Press. 2014;12:7–18. [DOI] [PubMed] [PMC]

112.

WHO [Internet]. Reducing Salt Intake in Populations: Report of a WHO Forum and Technical Meeting; c2006 [cited 2022 Apr 19]. Available from: https://apps.who.int/iris/bitstream/handle/10665/43653/9789241595377_eng.pdf

113.

Singh AK, Amlal H, Haas PJ, Dringenberg U, Fussell S, Barone SL, et al. Fructose-induced hypertension: essential role of chloride and fructose absorbing transporters PAT1 and Glut5. Kidney Int. 2008;74:438–47. [DOI] [PubMed]

114.

Barone S, Fussell SL, Singh AK, Lucas F, Xu J, Kim C, et al. Slc2a5 (Glut5) is essential for the absorption of fructose in the intestine and generation of fructose-induced hypertension. J Biol Chem. 2009;284:5056–66. [DOI] [PubMed] [PMC]

115.

Cabral PD, Hong NJ, Hye Khan MA, Ortiz PA, Beierwaltes WH, Imig JD, et al. Fructose stimulates Na/H exchange activity and sensitizes the proximal tubule to angiotensin II. Hypertension. 2014;63:e68–73. [DOI] [PubMed]

116.

Catena C, Cavarape A, Novello M, Giacchetti G, Sechi LA. Insulin receptors and renal sodium handling in hypertensive fructose-fed rats. Kidney Int. 2003;64:2163–71. [DOI] [PubMed]

117.

Gonzalez-Vicente A, Hong NJ, Yang N, Cabral PD, Berthiaume JM, Dominici FP, et al. Dietary fructose increases the sensitivity of proximal tubules to angiotensin II in rats fed high-salt diets. Nutrients. 2018;10:1244. [DOI] [PubMed] [PMC]

118.

Yang N, Gonzalez-Vicente A, Garvin JL. Angiotensin II-induced superoxide and decreased glutathione in proximal tubules: effect of dietary fructose. Am J Physiol Renal Physiol. 2020;318:F183–92. [DOI] [PubMed] [PMC]

119.

Singh M, Mensah GA, Bakris G. Pathogenesis and clinical physiology of hypertension. Cardiol Clin. 2010;28:545–59. [DOI] [PubMed]

120.

Dharmashankar K, Widlansky ME. Vascular endothelial function and hypertension: insights and directions. Curr Hypertens Rep. 2010;12:448–55. [DOI] [PubMed] [PMC]

121.

Katakam PVG, Ujhelyi MR, Hoenig ME, Miller AW. Endothelial dysfunction precedes hypertension in diet-induced insulin resistance. Am J Physiol. 1998;275:R788–92. [DOI] [PubMed]

122.

Palanisamy N, Venkataraman AC. Beneficial effect of genistein on lowering blood pressure and kidney toxicity in fructose-fed hypertensive rats. Br J Nutr. 2013;109:1806–12. [DOI] [PubMed]

123.

Okamura T, Tawa M, Geddawy A, Shimosato T, Iwasaki H, Shintaku H, et al. Effects of atorvastatin, amlodipine, and their combination on vascular dysfunction in insulin-resistant rats. J Pharmacol Sci. 2014;124:76–85. [DOI] [PubMed]

124.

Glushakova O, Kosugi T, Roncal C, Mu W, Heinig M, Cirillo P, et al. Fructose induces the inflammatory molecule ICAM-1 in endothelial cells. J Am Soc Nephrol. 2008;19:1712–20. [DOI] [PubMed] [PMC]

125.

Berenyiova A, Golas S, Drobna M, Cebova M, Cacanyiova S. Fructose intake impairs the synergistic vasomotor manifestation of nitric oxide and hydrogen sulfide in rat aorta. Int J Mol Sci. 2021;22:4749. [DOI] [PubMed] [PMC]

126.

Galipeau D, Arikawa E, Sekirov I, McNeill JH. Chronic thromboxane synthase inhibition prevents fructose-induced hypertension. Hypertension. 2001;38:872–6. [DOI] [PubMed]

127.

Ehrlich JR, Hohnloser SH, Nattel S. Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence. Eur Heart J. 2006;27:512–8. [DOI] [PubMed]

128.

Tran LT, MacLeod KM, McNeill JH. Endothelin-1 modulates angiotensin II in the development of hypertension in fructose-fed rats. Mol Cell Biochem. 2009;325:89. [DOI] [PubMed]

129.

Lin YJ, Juan CC, Kwok CF, Hsu YP, Shih KC, Chen CC, et al. Endothelin-1 exacerbates development of hypertension and atherosclerosis in modest insulin resistant syndrome. Biochem Biophys Res Commun. 2015;460:497–503. [DOI] [PubMed]

130.

Younossi ZM, Marchesini G, Pinto-Cortez H, Petta S. Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: implications for liver transplantation. Transplantation. 2019;103:22–7. [DOI] [PubMed]

131.

Solga S, Alkhuraishe AR, Clark JM, Torbenson M, Greenwald A, Diehl AM, et al. Dietary composition and nonalcoholic fatty liver disease. Dig Dis Sci. 2004;49:1578–83. [DOI] [PubMed]

132.

Toshimitsu K, Matsuura B, Ohkubo I, Niiya T, Furukawa S, Hiasa Y, et al. Dietary habits and nutrient intake in non-alcoholic steatohepatitis. Nutrition. 2007;23:46–52. [DOI] [PubMed]

133.

Nier A, Engstler AJ, Maier IB, Bergheim I. Markers of intestinal permeability are already altered in early stages of non-alcoholic fatty liver disease: studies in children. PLoS One. 2017;12:e0183282. [DOI] [PubMed] [PMC]

134.

Chung M, Ma J, Patel K, Berger S, Lau J, Lichtenstein AH. Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: a systematic review and meta-analysis. Am J Clin Nutr. 2014;100:833–49. [DOI] [PubMed] [PMC]

135.

Perrar I, Buyken AE, Penczynski KJ, Remer T, Kuhnle GG, Herder C, et al. Relevance of fructose intake in adolescence for fatty liver indices in young adulthood. Eur J Nutr. 2021;60:3029–41. [DOI] [PubMed] [PMC]

136.

Wehmeyer MH, Zyriax BC, Jagemann B, Roth E, Windler E, Schulze Zur Wiesch J, et al. Nonalcoholic fatty liver disease is associated with excessive calorie intake rather than a distinctive dietary pattern. Medicine (Baltimore). 2016;95:e3887. [DOI] [PubMed] [PMC]

137.

Schwarz JM, Noworolski SM, Wen MJ, Dyachenko A, Prior JL, Weinberg ME, et al. Effect of a high-fructose weight-maintaining diet on lipogenesis and liver fat. J Clin Endocrinol Metab. 2015;100:2434–42. [DOI] [PubMed] [PMC]

138.

Jin R, Le NA, Liu S, Farkas Epperson M, Ziegler TR, Welsh JA, et al. Children with NAFLD are more sensitive to the adverse metabolic effects of fructose beverages than children without NAFLD. J Clin Endocrinol Metab. 2012;97:E1088–98. [DOI] [PubMed] [PMC]

139.

Mager DR, Iniguez IR, Gilmour S, Yap J. The effect of a low fructose and low glycemic index/load (FRAGILE) dietary intervention on indices of liver function, cardiometabolic risk factors, and body composition in children and adolescents with nonalcoholic fatty liver disease (NAFLD). JPEN J Parenter Enteral Nutr. 2015;39:73–84. [DOI] [PubMed]

140.

Volynets V, Machann J, Kuper MA, Maier IB, Spruss A, Konigsrainer A, et al. A moderate weight reduction through dietary intervention decreases hepatic fat content in patients with non-alcoholic fatty liver disease (NAFLD): a pilot study. Eur J Nutr. 2013;52:527–35. [DOI] [PubMed]

141.

Schwimmer JB, Ugalde-Nicalo P, Welsh JA, Angeles JE, Cordero M, Harlow KE, et al. Effect of a low free sugar diet vs usual diet on nonalcoholic fatty liver disease in adolescent boys: a randomized clinical trial. JAMA. 2019;321:256–65. [DOI] [PubMed] [PMC]

142.

Nier A, Brandt A, Conzelmann IB, Özel Y, Bergheim I. Non-alcoholic fatty liver disease in overweight children: role of fructose intake and dietary pattern. Nutrients. 2018;10:1329. [DOI] [PubMed] [PMC]

143.

Jegatheesan P, De Bandt JP. Fructose and NAFLD: the multifaceted aspects of fructose metabolism. Nutrients. 2017;9:230. [DOI] [PubMed] [PMC]

144.

Spruss A, Bergheim I. Dietary fructose and intestinal barrier: potential risk factor in the pathogenesis of nonalcoholic fatty liver disease. J Nutr Biochem. 2009;20:657–62. [DOI] [PubMed]

145.

Kanuri G, Spruss A, Wagnerberger S, Bischoff SC, Bergheim I. Fructose-induced steatosis in mice: role of plasminogen activator inhibitor-1, microsomal triglyceride transfer protein and NKT cells. Lab Invest. 2011;91:885–95. [DOI] [PubMed]

146.

Tilg H, Adolph TE, Dudek M, Knolle P. Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity. Nature Metabolism. 2021;3:1596–607. [DOI] [PubMed]

147.

Brandt A, Hernandez-Arriaga A, Kehm R, Sanchez V, Jin CJ, Nier A, et al. Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestine. Sci Rep. 2019;9:6668. [DOI] [PubMed] [PMC]

148.

Wagnerberger S, Spruss A, Kanuri G, Volynets V, Stahl C, Bischoff SC, et al. Toll-like receptors 1–9 are elevated in livers with fructose-induced hepatic steatosis. Br J Nutr. 2012;107:1727–38. [DOI] [PubMed]

149.

Baumann A, Rajcic D, Brandt A, Sánchez V, Jung F, Staltner R, et al. Alterations of nitric oxide homeostasis as trigger of intestinal barrier dysfunction in non-alcoholic fatty liver disease. J Cell Mol Med. 2022;26:1206–18. [DOI] [PubMed] [PMC]

150.

Rajcic D, Baumann A, Hernández-Arriaga A, Brandt A, Nier A, Jin CJ, et al. Citrulline supplementation attenuates the development of non-alcoholic steatohepatitis in female mice through mechanisms involving intestinal arginase. Redox Biol. 2021;41:101879. [DOI] [PubMed] [PMC]

151.

Spruss A, Kanuri G, Stahl C, Bischoff SC, Bergheim I. Metformin protects against the development of fructose-induced steatosis in mice: role of the intestinal barrier function. Lab Invest. 2012;92:1020–32. [DOI] [PubMed]

152.

Jegatheesan P, Beutheu S, Ventura G, Sarfati G, Nubret E, Kapel N, et al. Effect of specific amino acids on hepatic lipid metabolism in fructose-induced non-alcoholic fatty liver disease. Clinical Nutrition. 2016;35:175–82. [DOI] [PubMed]

153.

Zhang Y, Wang L, Zhang J, Li Y, He Q, Li H, et al. Probiotic Lactobacillus casei Zhang ameliorates high-fructose-induced impaired glucose tolerance in hyperinsulinemia rats. Eur J Nutr. 2014;53:221–32. [DOI] [PubMed]

154.

Jegatheesan P, Beutheu S, Freese K, Waligora-Dupriet AJ, Nubret E, Butel MJ, et al. Preventive effects of citrulline on Western diet-induced non-alcoholic fatty liver disease in rats. Br J Nutr. 2016;116:191–203. [DOI] [PubMed]

155.

Jin R, Willment A, Patel SS, Sun X, Song M, Mannery YO, et al. Fructose induced endotoxemia in pediatric nonalcoholic fatty liver disease. Int J Hepatol. 2014;2014:560620. [DOI] [PubMed] [PMC]

156.

Alemán JO, Henderson WA, Walker JM, Ronning A, Jones DR, Walter PJ, et al. Excess dietary fructose does not alter gut microbiota or permeability in humans: a pilot randomized controlled study. J Clin Transl Sci. 2021;5:e143. [DOI] [PubMed] [PMC]

157.

Zhu JZ, Hollis-Hansen K, Wan XY, Fei SJ, Pang XL, Meng FD, et al. Clinical guidelines of non-alcoholic fatty liver disease: a systematic review. World J Gastroenterol. 2016;22:8226–33. [DOI] [PubMed] [PMC]

158.

Yan RR, Bun Chan C, Chun Yu Louie J. Current WHO recommendation to reduce free sugar intake from all sources to below 10% of daily energy intake for supporting overall health is not well-supported by available evidence. Am J Clin Nutr. 2022;116:15–39. [DOI] [PubMed] [PMC]

159.

Ernst JB, Arens-Azevedo U, Bitzer B, Bosy-Westphal A, de Zwaan M, Egert S, et al. Deutsche Adipositas-Gesellschaft, Deutsche Diabetes Gesellschaft und Deutsche Gesellschaft für Ernährung. Quantitative Empfehlung zur Zuckerfuhr in Deutschland. Bonn. 2018:1–32. German.